Eli Lilly is the pharmaceutical company that developed the diabetes drug Mounjaro and uses the stock ticker LLY.
Colonel Eli Lilly founded the company in Indianapolis, Indiana, in 1876. It became known for producing insulin, antibiotics, psychiatric medicines, and other prescription treatments. The company’s long history in diabetes care helped establish it as a major global pharmaceutical manufacturer.
Mounjaro is the brand name for tirzepatide, which the U.S. Food and Drug Administration approved in 2022 for adults with type 2 diabetes alongside diet and exercise. Tirzepatide acts on both GIP and GLP-1 receptors. Eli Lilly markets a separate tirzepatide product, Zepbound, for chronic weight management in eligible adults.
Mounjaro and Zepbound are sometimes confused because they contain the same active ingredient but have different approved uses and brand identities. Eli Lilly’s common stock trades on the New York Stock Exchange under LLY.